The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Edward Tsai

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Edward Tsai is a venture capital based in New York across 1,800 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Edward Tsai on Aerospace Defense, Artificial Intelligence and Crypto Web3.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Edward Tsai — Venture Capital
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Edward Tsai — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Edward Tsai — 1,800
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Edward Tsai — Aerospace Defense, Artificial Intelligence, Crypto Web3

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Edward Tsai — Venture Capital · New York · 1,800 tracked deals · Edward Tsai portfolio

Similar investors

• Strategic Equity Capital NY LLC
• Harsha Marti
• Daniel Fabian
• Elodie Dupuy
• Lexington Partners GP Holdings X, L.L.C.
• Fady Abdel-Nour
• Pal B. Ristvedt
• Antler Special Opportunities GP II LLC
• iCapital Strategies LLC
• Pete Mathias

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Edward Tsai · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory